Home > Products > CD28 & CD44 > Recombinant Anti-CD28 x Anti-CD44 Bispecific Antibody (Tandem scFv)

Recombinant Anti-CD28 x Anti-CD44 Bispecific Antibody (Tandem scFv)  (BSFV-057)

Recombinant Anti-CD28 x Anti-CD44 Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-CD28 antibody variable domains fused with a scFv from an anti-CD44 antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can retarget T cells to tumor cells. It is designed for the research of Glioblastoma; Squamous cancer therapy.

Specifications

Targets
CD28 & CD44
Type
Tandem scFv
Species Reactivity
Human
Target 1
CD28
Host Animal 1
Mouse
Target 2
CD44
Host Animal 2
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
Glioblastoma; Squamous cancer

Targets

Target 1
CD28
Gene ID
UniProt ID
Alternative Names
CD28; CD28 molecule; Cluster of Differentiation 28; Tp44; T-cell-specific surface glycoprotein CD28; CD28 antigen
Target 2
CD44
Gene ID
UniProt ID
Alternative Names
CD44; CD44 antigen; ECMRIII; Extracellular matrix receptor III; HCAM; Homing cell adhesion molecule; Pgp-1; phagocytic glycoprotein-1; HUTCH-1; Ly-24; Pgp-1; HERMES; AU023126; AW121933; AW146109

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD28 x Anti-CD44 Bispecific Antibody (Tandem scFv) (BSFV-057). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CD28 & CD44"
Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: